Outcome measures were obtained at baseline (immediately prior to dosing), and after 6 months.
Patients were followed for 36 weeks, and cognitive assessments were obtained at baseline and at 12, 24, and 36 weeks.
Wound cultures were obtained at baseline and thereafter as was considered clinically relevant.
For predictor variables we used items from the baseline ASI, the baseline UDS and CSSA scores obtained at baseline.
Overnight timed urine collections were obtained at baseline, 8 and 16 weeks to UAE.
Pre-and postbronchodilator spirometry was obtained at baseline and 8 weeks.
Blood samples were obtained at baseline and immediately after each endurance test.
The coronary angiograms obtained at baseline and follow-up were evaluated.
CSF and plasma were obtained at baseline and weeks 8, 16, and 48.
Self-reported and physiologic measures were obtained at baseline, 6 weeks, and 10 weeks.
Test retest correlations were calculated between measures obtained at baseline and at 3 months.
